Medicine
fromNews Center
1 week agoNew Study Gives Answers, Drug Targets for Chronic Lung-transplant Rejection - News Center
Donor structural cells interacting with recipient immune cells drive chronic lung allograft dysfunction, causing rejection and scarring in over half of recipients within five years.